Genmab A/S (CPH:GMAB)
Denmark
· Delayed Price · Currency is DKK 1,299.00
+14.00 (1.09%)
Apr 4, 2025, 11:59 AM CET
Genmab Market Cap
Genmab has a market cap or net worth of 81.66 billion as of April 4, 2025. Its market cap has decreased by -38.82% in one year.
Market Cap
81.66B
Enterprise Value
61.59B
Revenue
21.53B
Ranking
n/a
PE Ratio
10.59
Stock Price
1,299.00
Market Cap Chart
Since October 18, 2000, Genmab's market cap has increased from 3.68B to 81.66B, an increase of 2,116.55%. That is a compound annual growth rate of 13.50%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 2,027.98B |
| Coloplast | 157.71B |
| Demant | 47.42B |
| Zealand Pharma | 32.73B |
| ALK-Abelló | 31.50B |
| H. Lundbeck | 30.91B |
| Ambu A/S | 29.18B |
| GN Store Nord | 14.49B |